Abstract |
We describe neonatal hepatitis B virus (HBV) vaccine policies in Colorado before and after thimerosal recommendations, plans for use of thimerosal-free HBV vaccine, and nurses' awareness of high-risk criteria for HBV vaccination. The results suggest that fewer neonates are receiving HBV vaccine at birth hospitals.
|
Authors | R M Brayden, K A Pearson, J S Jones, B L Renfrew, S Berman |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 138
Issue 5
Pg. 752-5
(May 2001)
ISSN: 0022-3476 [Print] United States |
PMID | 11343056
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Hepatitis B Vaccines
- Preservatives, Pharmaceutical
- Thimerosal
|
Topics |
- Centers for Disease Control and Prevention, U.S.
- Guideline Adherence
(standards)
- Hepatitis B
(prevention & control)
- Hepatitis B Vaccines
(adverse effects, therapeutic use)
- Hospitals, Maternity
- Humans
- Infant, Newborn
- Preservatives, Pharmaceutical
(adverse effects)
- Public Health
- Risk Factors
- Thimerosal
(adverse effects)
- United States
|